The brainstem houses the respiratory centres, which are responsible for regulating various aspects of breathing. These centres are located in the upper pons, lower pons and medulla oblongata.

The thalamus plays a role in sensory, motor and cognitive functions, and its axons connect with the cerebral cortex. The cerebellum coordinates voluntary movements and helps maintain balance and posture. The parietal lobe processes sensory information, including discrimination and body orientation. The primary visual cortex is located in the occipital lobe.

The Control of Ventilation in the Human Body

The control of ventilation in the human body is a complex process that involves various components working together to regulate the respiratory rate and depth of respiration. The respiratory centres, chemoreceptors, lung receptors, and muscles all play a role in this process. The automatic, involuntary control of respiration occurs from the medulla, which is responsible for controlling the respiratory rate and depth of respiration.

The respiratory centres consist of the medullary respiratory centre, apneustic centre, and pneumotaxic centre. The medullary respiratory centre has two groups of neurons, the ventral group, which controls forced voluntary expiration, and the dorsal group, which controls inspiration. The apneustic centre, located in the lower pons, stimulates inspiration and activates and prolongs inhalation. The pneumotaxic centre, located in the upper pons, inhibits inspiration at a certain point and fine-tunes the respiratory rate.

Ventilatory variables, such as the levels of pCO2, are the most important factors in ventilation control, while levels of O2 are less important. Peripheral chemoreceptors, located in the bifurcation of carotid arteries and arch of the aorta, respond to changes in reduced pO2, increased H+, and increased pCO2 in arterial blood. Central chemoreceptors, located in the medulla, respond to increased H+ in brain interstitial fluid to increase ventilation. It is important to note that the central receptors are not influenced by O2 levels.

Lung receptors also play a role in the control of ventilation. Stretch receptors respond to lung stretching, causing a reduced respiratory rate, while irritant receptors respond to smoke, causing bronchospasm. J (juxtacapillary) receptors are also involved in the control of ventilation. Overall, the control of ventilation is a complex process that involves various components working together to regulate the respiratory rate and depth of respiration.

The presence of adult-onset asthma, eosinophilia, and a positive pANCA test strongly suggests a diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) in this patient.

Although GPA can cause epistaxis, the absence of other characteristic symptoms such as saddle-shaped nose deformity, haemoptysis, renal failure, and positive cANCA make EGPA a more likely diagnosis.

Polyarteritis Nodosa, Temporal Arteritis, and Toxic Epidermal Necrolysis have distinct clinical presentations that do not match the symptoms exhibited by this patient.

Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome)

Eosinophilic granulomatosis with polyangiitis (EGPA), previously known as Churg-Strauss syndrome, is a type of small-medium vessel vasculitis that is associated with ANCA. It is characterized by asthma, blood eosinophilia (more than 10%), paranasal sinusitis, mononeuritis multiplex, and pANCA positivity in 60% of cases.

Compared to granulomatosis with polyangiitis, EGPA is more likely to have blood eosinophilia and asthma as prominent features. Additionally, leukotriene receptor antagonists may trigger the onset of the disease.

Overall, EGPA is a rare but serious condition that requires prompt diagnosis and treatment to prevent complications.

Benign paroxysmal positional vertigo (BPPV) is suspected based on the patient’s history. To confirm the diagnosis, the Dix-Hallpike manoeuvre can be performed, which involves quickly moving the patient from a sitting to supine position and observing for nystagmus.

If BPPV is confirmed, the Epley manoeuvre can be used for treatment. This manoeuvre aims to dislodge otoliths by promoting fluid movement in the inner ear’s semicircular canals.

Carpal tunnel syndrome can be diagnosed by a positive Tinel’s sign. This involves tapping the median nerve over the flexor retinaculum, causing paraesthesia in the median nerve’s distribution.

The Trendelenburg test is used to assess venous valve competency in patients with varicose veins.

Benign paroxysmal positional vertigo (BPPV) is a common cause of vertigo that occurs suddenly when there is a change in head position. It is more prevalent in individuals over the age of 55 and is less common in younger patients. Symptoms of BPPV include dizziness and vertigo, which can be accompanied by nausea. Each episode typically lasts for 10-20 seconds and can be triggered by rolling over in bed or looking upwards. A positive Dix-Hallpike manoeuvre, which is indicated by vertigo and rotatory nystagmus, can confirm the diagnosis of BPPV.

Fortunately, BPPV has a good prognosis and usually resolves on its own within a few weeks to months. Treatment options include the Epley manoeuvre, which is successful in around 80% of cases, and vestibular rehabilitation exercises such as the Brandt-Daroff exercises. While medication such as Betahistine may be prescribed, it tends to have limited effectiveness. However, it is important to note that around half of individuals with BPPV may experience a recurrence of symptoms 3-5 years after their initial diagnosis.

COPD is typically found in older smokers, but non-smokers with A-1 antitrypsin deficiency may also develop the condition. This genetic condition is tested for with genetic and blood tests, as the protein it affects would normally protect lung cells from damage caused by neutrophil elastase. C1 inhibitor is not related to early onset COPD, but rather plays a role in hereditary angioedema. Plasminogen activator inhibitor-1 deficiency increases the risk of fibrinolysis, while surfactant protein D deficiency is associated with a higher likelihood of bacterial lung infections due to decreased ability of alveolar macrophages to bind to pathogens. Emphysema is primarily caused by uninhibited action of neutrophil elastase due to a1- antitrypsin deficiency, rather than elastin destruction.

Alpha-1 antitrypsin (A1AT) deficiency is a genetic condition that occurs when the liver does not produce enough of a protein called protease inhibitor (Pi). This protein is responsible for protecting cells from enzymes like neutrophil elastase. A1AT deficiency is inherited in an autosomal recessive or co-dominant manner and is located on chromosome 14. The alleles are classified by their electrophoretic mobility, with M being normal, S being slow, and Z being very slow. The normal genotype is PiMM, while heterozygous individuals have PiMZ. Homozygous PiSS individuals have 50% normal A1AT levels, while homozygous PiZZ individuals have only 10% normal A1AT levels.

A1AT deficiency is most commonly associated with panacinar emphysema, which is a type of chronic obstructive pulmonary disease (COPD). This is especially true for patients with the PiZZ genotype. Emphysema is more likely to occur in non-smokers with A1AT deficiency, but they may still pass on the gene to their children. In addition to lung problems, A1AT deficiency can also cause liver issues such as cirrhosis and hepatocellular carcinoma in adults, and cholestasis in children.

Diagnosis of A1AT deficiency involves measuring A1AT concentrations and performing spirometry to assess lung function. Management of the condition includes avoiding smoking and receiving supportive care such as bronchodilators and physiotherapy. Intravenous alpha1-antitrypsin protein concentrates may also be used. In severe cases, lung volume reduction surgery or lung transplantation may be necessary.